| Pathogenic Bordetella Rapid Detection (NCT04535505) | Children's Hospital of Fudan University | 2022-07-01 |
| Establishing a Controlled Human Infection Model of Bordetella Pertussis (NCT05136599) | Dalhousie University | 2022-01-28 |
| Pertussis Acellular Vaccine Adjuvanted With TQL1055 (NCT04793620) | Adjuvance Technologies, Inc. | 2021-04-06 |
| A Multi-center Study to Determine the Prevalence and Influence of Pertussis on COPD Exacerbation in Shenzhen (NCT04694430) | Shenzhen People's Hospital | 2021-01-01 |
| A Multi-center Study to Determine the Prevalence and Influence of Pertussis on Subacute Cough in Shenzhen (NCT04694963) | Shenzhen People's Hospital | 2021-01-01 |
| Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays (NCT04023929) | St George's, University of London | 2020-10-28 |
| Maternal Pertussis Wholecell Responses (NCT04589312) | St George's, University of London | 2020-10-21 |
| 5-year Follow-up After a Single Dose Acellular Pertussis Vaccination (NCT04529720) | Mahidol University | 2020-08-24 |
| Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . (NCT04099303) | CanSino Biologics Inc. | 2020-04-28 |
| To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years (NCT04618640) | Boryung Biopharma Co., Ltd. | 2019-12-26 |
| Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants (NCT04073459) | LG Chem | 2019-11-01 |
| A Phase IV Study to Assess the Safety of EupentaTM Inj (NCT04056728) | LG Chem | 2019-09-23 |
| Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults (NCT03942406) | ILiAD Biotechnologies | 2019-06-15 |
| Pertussis Vaccination in Pregnant Women (NCT03909126) | St. Justine's Hospital | 2019-06-01 |
| Optimising the Timing of Whooping Cough Immunisation in MUMs (NCT03908164) | St George's, University of London | 2019-05-07 |
| Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants (NCT03589768) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-24 |
| Gambia Pertussis Study (GaPs) (NCT03606096) | London School of Hygiene and Tropical Medicine | 2019-01-23 |
| Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults (NCT03541499) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-10-23 |
| Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System (NCT03950986) | Atlanta VA Medical Center | 2018-10-15 |
| Maternal Antibody in Milk After Vaccination (NCT03982732) | St George's, University of London | 2018-08-07 |
| Evaluation of an Infant Immunization Encouragement Program in Nigeria (NCT03870061) | GiveWell | 2018-07-01 |
| 3-year Follow-up After a Single Dose Acellular Pertussis Vaccination (NCT04102137) | Mahidol University | 2018-06-26 |
| Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women (NCT03498300) | Mahidol University | 2018-05-09 |
| A Study Exploring Whooping Cough Protection in Children and Adults (NCT03697798) | University of Oxford | 2018-04-18 |
| The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks (NCT03931239) | Vabiotech | 2018-03-01 |
| Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan (NCT03341195) | Aga Khan University | 2018-01-01 |
| Adacel® Booster Vaccination for CMI Assay Development (NCT04543669) | Dalhousie University | 2017-07-12 |
| The Feasibility of Pertussis Immunization in a Canadian Emergency Department (NCT03304275) | University of Prince Edward Island | 2017-07-10 |
| A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults (NCT03208101) | LG Chem | 2017-07-03 |
| 2-year Follow-up After a Single Dose Acellular Pertussis Vaccination (NCT04113655) | Mahidol University | 2017-06-20 |
| Observational Study Describing the Immune Profile Induced By Pertussis Vaccines (NCT03147898) | Sanofi | 2017-04-12 |
| CD8 Reactivity to Microorganisms in Blood and Breast Milk (NCT03084614) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-28 |
| Pertussis Immunization During Pregnancy & HIV Infection (NCT03519373) | Centre Hospitalier Universitaire Saint Pierre | 2017-03-01 |
| The PertADO Geneva Trial (NCT02946190) | Siegrist Claire-Anne | 2016-10-27 |
| A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia (NCT02858440) | GlaxoSmithKline | 2016-09-13 |
| DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants (NCT02817451) | Sanofi Pasteur, a Sanofi Company | 2016-07-14 |
| Maternal Tdap Immunization in Guatemala (NCT02301702) | Emory University | 2016-07-01 |
| Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) (NCT02759354) | MCM Vaccines B.V. | 2016-04-26 |
| Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda (NCT04177485) | Centers for Disease Control and Prevention | 2016-02-01 |
| Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects (NCT02587520) | Sanofi Pasteur, a Sanofi Company | 2015-10-22 |
| Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine (NCT02453048) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-09-01 |
| Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth (NCT02428491) | Sanofi Pasteur, a Sanofi Company | 2015-04-20 |
| Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand (NCT02408926) | Universiteit Antwerpen | 2015-04-01 |
| Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) (NCT02382913) | Novartis | 2015-04-01 |
| Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks (NCT02257645) | LG Life Sciences | 2015-03-01 |
| Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS (NCT02458183) | Boryung Pharmaceutical Co., Ltd | 2015-02-02 |
| Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants (NCT02511327) | Universiteit Antwerpen | 2015-01-01 |
| Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation (NCT01890447) | GlaxoSmithKline | 2015-01-01 |
| DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants (NCT02274285) | Sanofi Pasteur, a Sanofi Company | 2014-10-01 |
| TDAP Safety in Pregnant Women (NCT02209623) | Vanderbilt University | 2014-05-01 |
| A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary (NCT02014519) | GlaxoSmithKline | 2014-04-24 |
| Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents (NCT02118961) | Tanabe Pharma Corporation | 2014-04-01 |
| Boostrix® Pregnancy Registry (NCT02096276) | GlaxoSmithKline | 2014-03-31 |
| Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old (NCT02089347) | Sanofi Pasteur, a Sanofi Company | 2014-03-01 |
| DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants (NCT02094833) | Sanofi Pasteur, a Sanofi Company | 2014-03-01 |
| Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants (NCT02477995) | Jiangsu Province Centers for Disease Control and Prevention | 2013-12-01 |
| Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. (NCT01993173) | Sanofi Pasteur, a Sanofi Company | 2013-11-01 |
| How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice (NCT01979588) | Endeavor Health | 2013-11-01 |
| Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya (NCT01878435) | Johns Hopkins Bloomberg School of Public Health | 2013-10-01 |
| A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject (NCT01917357) | Crucell Holland BV | 2013-09-01 |
| Pertussis and Meningitis C Concomitant Vaccination in Adolescents (NCT02526394) | Public Health England | 2013-09-01 |
| Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China (NCT01933776) | Sanofi Pasteur, a Sanofi Company | 2013-08-01 |
| Protecting Pregnant Women From Infectious Diseases (NCT01761799) | Emory University | 2012-12-01 |
| Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals (NCT01706224) | GlaxoSmithKline | 2012-11-01 |
| Tdap Vaccine in Post-Partum Women (NCT01711645) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-26 |
| Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents (NCT01689324) | Sanofi Pasteur, a Sanofi Company | 2012-09-01 |
| Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age (NCT01659996) | Sanofi Pasteur, a Sanofi Company | 2012-07-01 |
| Pertussis Infection in Adolescents and Adults With Prolonged Cough (NCT01597687) | GlaxoSmithKline | 2012-06-20 |
| Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents (NCT01629589) | Sanofi Pasteur, a Sanofi Company | 2012-06-01 |
| Pertussis (Tdap) Vaccination in Pregnancy (NCT01698346) | Universiteit Antwerpen | 2012-02-01 |
| Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China (NCT01491087) | Sanofi Pasteur, a Sanofi Company | 2011-12-01 |
| Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age (NCT01470287) | Novartis Vaccines | 2011-12-01 |
| Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose (NCT01439165) | Sanofi Pasteur, a Sanofi Company | 2011-11-01 |
| Regulatory Post-Marketing Surveillance Study for TETRAXIM™ (NCT01437423) | Sanofi Pasteur, a Sanofi Company | 2011-06-01 |
| Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination (NCT01357720) | Crucell Holland BV | 2011-05-01 |
| Testing the Use of Prompts to Increase Adolescent Immunization Rates (NCT01984125) | University of California, Los Angeles | 2011-04-01 |
| Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age (NCT01346293) | Sanofi Pasteur, a Sanofi Company | 2011-04-01 |
| Study of Adacel® Vaccine Administered to Persons 10 Years of Age (NCT01311557) | Sanofi | 2011-03-01 |
| Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older (NCT01287949) | Sanofi Pasteur, a Sanofi Company | 2011-01-01 |
| Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. (NCT01214889) | Sanofi | 2010-09-01 |
| First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine (NCT01188512) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-08-01 |
| Post Marketing Surveillance for ADACEL™ in South Korea (NCT01137435) | Sanofi Pasteur, a Sanofi Company | 2010-06-01 |
| Tdap Vaccination for Infant Caregivers (NCT01233401) | Yale University | 2010-06-01 |
| Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B (NCT01362517) | Crucell Holland BV | 2010-04-01 |
| Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines (NCT01129362) | Sanofi Pasteur, a Sanofi Company | 2010-02-08 |
| A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants (NCT01062477) | Sanofi | 2010-01-01 |
| A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) (NCT01003431) | Merck Sharp & Dohme LLC | 2009-12-01 |
| A Study to Assess the Safety of Adacel® Vaccine (NCT01040052) | Sanofi Pasteur, a Sanofi Company | 2009-12-01 |
| Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age (NCT01031303) | Sanofi | 2009-12-01 |
| An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster (NCT00870350) | Swedish Institute for Infectious Disease Control | 2009-04-01 |
| Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease (NCT00855855) | Sanofi Pasteur, a Sanofi Company | 2009-02-01 |
| Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine (NCT00877357) | Shantha Biotechnics Limited | 2009-01-01 |
| Pertussis Vaccine in Healthy Pregnant Women (NCT00707148) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting (NCT00828555) | Duke University | 2008-11-01 |
| Immunogenicity and Safety of Adacel Polio Vaccine (NCT00797511) | Sanofi | 2008-11-01 |
| Database Surveillance Safety Study of PENTACEL® Vaccine (NCT00804284) | Sanofi Pasteur, a Sanofi Company | 2008-09-01 |
| Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose (NCT00712959) | Sanofi Pasteur, a Sanofi Company | 2008-06-01 |
| Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants (NCT00831753) | Sanofi Pasteur, a Sanofi Company | 2008-05-01 |
| Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ (NCT00654901) | Sanofi Pasteur, a Sanofi Company | 2008-03-01 |
| Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine (NCT00617812) | Shantha Biotechnics Limited | 2008-03-01 |